The prognostic impact of minimal residual disease in patients with chronic lymphocytic leukemia requiring first-line therapy
Publication date:
2014
Publisher version:
Citación:
Haematologica, 99(5), p. 873-880 (2014); doi:10.3324/haematol.2013.099796
Descripción física:
p. 873-880
Identificador local:
20141899
Patrocinado por:
This work was supported by research funding from the Spanish Ministry of Science and Innovation(MICINN) through the Instituto de Salud Carlos III(ISCIII)(ICGC-CLL Genome Project)and Red Temática de Investigación Cooperativa en Cáncer(RTICC)grants RD06/0020/0039, RD06/0020/0051 and RD12/0036/0023.
Collections
- Artículos [36888]
- Bioquímica y Biología Molecular [270]
- Investigaciones y Documentos OpenAIRE [8113]
Files in this item
